Vimarsana
Biggest News Aggregation in the World

Delivery Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Delivery Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Delivery Sciences Today - Breaking & Trending Today

CNBC Squawk On The Street September 4, 2014 - Vimarsana News

CNBC Squawk On The Street September 4, 2014

Numbers here tomorrow. Apples worse day in seven months. Apple now moving higher in the premarket. Yum sales take a hit in china after food safety scares, numbers from costco, and nevada lays out the welcome mat for musk, the 5 billion factory going to the desert. Ecb cut Interest Rates to new record lows in effort to ward off deflation, lowering the rate by a tenth percent, and its rate on bank overnight deposits to negative. 2 . The president says the bank will purchase asset backed securities, and here in the states, adp says prooifts sector hired 204 thourks worker last month, below foreca...

Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI - Vimarsana News

Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI

JUPITER, Fla. & DURHAM - Ligand Pharmaceuticals today announced the launch of Pelthos Therapeutics , a biopharmaceutical company, and the appointment of seasoned industry executive Scott Plesha to...

Shareholder Alert: Ademi LLP investigates whether BioDelivery Sciences International, Inc. has obtained a Fair Price in its transaction with Collegium. - Vimarsana News

Shareholder Alert: Ademi LLP investigates whether BioDelivery Sciences International, Inc. has obtained a Fair Price in its transaction with Collegium.

/PRNewswire/ -- Ademi LLP is investigating BioDelivery Sciences (NASDAQ: BDSI) for possible breaches of fiduciary duty and other violations of law in its...

Collegium Pharma Broadens Its Pain Portfolio With $600M BioDelivery Sciences Deal - Vimarsana News

Collegium Pharma Broadens Its Pain Portfolio With $600M BioDelivery Sciences Deal

Collegium Pharmaceutical Inc (NASDAQ:COLL) will acquire BioDelivery Sciences International Inc (NASDAQ:BDSI) at $5.60 per share in ...

Merger Mania Is Sending These 2 Little-Known Stocks Soaring - Vimarsana News

Merger Mania Is Sending These 2 Little-Known Stocks Soaring

Markets opened lower on Monday morning, but nothing held these two companies back.

Source: fool.com